Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond

FHS
June 18, 2024
4:32 am

A recent review in Diabetes Care evaluates the efficacy and safety of GLP-1 receptor agonists for type 2 diabetes and obesity, exploring their potential for new medical indications.

Mapping the human body one cell at a time: New study reveals the intricate relationship between cell size and count

A study published in PNAS provides a comprehensive look at the relationship between cell size and count across the human body, drawing from over 1,500

September 20, 2023

Pixel Watch 3 Introduces Loss of Pulse Detection Feature

[embedded content] What You Should Know: – Google launches Loss of Pulse Detection, a new feature on Pixel Watch 3 designed to save lives. –

August 14, 2024

Understanding the link between high-fat diets, insulin resistance, and diabetic heart disease

The relationship between a high-fat diet and increased risk of Type 2 diabetes and heart disease is well-known. But what is the connection and how

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.